A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma
Running, not enrolling · Phase 3
Conditions studied: Multiple Myeloma
In brief
The goal of this study (iMMagine-3) is to compare the study drug, anitocabtagene autoleucel to standard of care therapy (SOCT) in participants with relapsed/refractory multiple myeloma who have received 1 to 3 prior lines of therapy, including an anti-CD38 monoclonal antibody and an immunomodulatory drug. The primary objective of this study is to compare the efficacy of anitocabtagene autoleucel versus SOCT in participants with RRMM.
Key facts
- Study ID
- NCT06413498
- Run by
- Kite, A Gilead Company
- People needed
- 452
- Starts
- 2024-08-23
- Expected to finish
- 2031-07-01
- Last updated by the study team
- 2026-07-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mayo Clinic Hospital — Gilbert, Arizona, United States
- City of Hope (City of Hope National Medical Center, City of Hope Medical Center) — Duarte, California, United States
- USC/Norris Comprehensive Cancer Center — Los Angeles, California, United States
- University of California Davis Comprehensive Cancer Center — Sacramento, California, United States
- UC San Diego Moores Cancer Center — San Diego, California, United States
- UCLA Hematology/Oncology (Bowyer Infusion Clinic) — Santa Monica, California, United States
- Stanford Cancer Institute — Stanford, California, United States
- Colorado Blood Cancer Institute — Denver, Colorado, United States
- Sylvester Comprehensive Cancer Center — Coral Gables, Florida, United States
- Mayo Clinic — Jacksonville, Florida, United States
- Moffitt Cancer Center — Tampa, Florida, United States
- Winship Cancer Institute, Emory University — Atlanta, Georgia, United States
- Southeastern Regional Medical Center, Inc. dba City of Hope Atlanta — Newnan, Georgia, United States
- St. Luke's Cancer Institute — Boise, Idaho, United States
- University of Illinois Hospital and Health Sciences System — Chicago, Illinois, United States
- IU Melvin and Bren Simon Comprehensive Cancer Center — Indianapolis, Indiana, United States
- Norton Cancer Institute, St. Matthews Campus — Louisville, Kentucky, United States
- Ochsner Clinical Foundation — New Orleans, Louisiana, United States
- University of Maryland Greenebaum Comprehensive Cancer Center — Baltimore, Maryland, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Boston Medical Center — Boston, Massachusetts, United States
- University of Michigan — Ann Arbor, Michigan, United States
- Corewell Health - Lemmen-Holton Cancer Pavilion — Grand Rapids, Michigan, United States
- Mayo Clinic — Rochester, Minnesota, United States
- Banner MD Anderson Cancer Center — Gilbert, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.